October « 2014 « Science and Enterprise

Graphene Sensor Offers Clear Optical Access to Brain Cells

By Alan, on October 22nd, 2014%

Blue light shines through a clear sensor implanted in the brain of a lab animal. (Williams research group, Univ of Wisconsin – Madison)

22 October 2014. Engineers at University of Wisconsin in Madison developed an implanted transparent sensor made with graphene that allows for imaging and diagnostics in the brain requiring line-of-sight access. . . . → Read More: Graphene Sensor Offers Clear Optical Access to Brain Cells

Project Developing DNA Antibodies for Infectious Diseases

By Alan, on October 21st, 2014%

3-D image of MRSA bacteria (Melissa Brower, CDC)

21 October 2014. The biotechnology company Inovio Pharmaceuticals Inc. and partners are developing synthetic antibodies based on DNA that generate an immune reaction to prevent infectious diseases, a project funded by Department of Defense Advanced Research Projects Agency or DARPA. The $12.2 million DARPA grant . . . → Read More: Project Developing DNA Antibodies for Infectious Diseases

Genomic Data Analysis Service Launches, Hosts Autism Data

By Alan, on October 20th, 2014%

(Wikimedia Commons)

20 October 2014. NextCode Health, a start-up informatics company in Cambridge, Massachusetts, unveiled its NextCode Exchange, a shared online genomics database and analysis service for diagnostics and research with sequencing data. The 1 year-old company also is hosting a genomics database of people with autism for online access to researchers.

NextCode . . . → Read More: Genomic Data Analysis Service Launches, Hosts Autism Data

FDA Exemption Sought for Ebola Blood Plasma Device

By Alan, on October 20th, 2014%

Scanning electron micrograph of Ebola virus (National Institute of Allergy and Infectious Diseases)

20 October 2014. Cerus Corp., a developer of blood safety devices, is asking the U.S. Food and Drug Administration to allow its system for removing pathogens from blood plasma be used to treat patients in the U.S. with Ebola, while . . . → Read More: FDA Exemption Sought for Ebola Blood Plasma Device

Better DNA Sample Prep Methods Sought in Challenge

By Alan, on October 17th, 2014%

(James. J. Caras, National Science Foundation)

17 October 2014. A new challenge on InnoCentive is seeking methods that make it possible to prepare DNA samples in the field for sequencing, based on smaller quantities of microbial evidence. The challenge has an award of $25,000 and a deadline of 7 December 2014.

InnoCentive in . . . → Read More: Better DNA Sample Prep Methods Sought in Challenge

Simple 3-D Graphene Construction Process Devised

By Alan, on October 17th, 2014%

Electron microscope image of porous graphene-based structure created by diffusion driven layer-by-layer assembly (Kyoto University)

17 October 2014. Materials scientists at Kyoto University in Japan developed a new process that simplifies the building of three-dimension structures with graphene, a light, strong, conductive material with many industrial and commercial applications. Franklin Kim and Jianli . . . → Read More: Simple 3-D Graphene Construction Process Devised

Personalized Leukemia Immunotherapy Gets 90 Pct Remission

By Alan, on October 16th, 2014%

T-cell (NIAID/NIH)

16 October 2014. Nine in 10 children and adults in early-stage clinical trials of a personalized therapy harnessing the patients’ immune systems achieved full remission of their acute lymphoblastic leukemia. The findings of the team from University of Pennsylvania and Children’s Hospital of Philadelphia are reported today in New England Journal . . . → Read More: Personalized Leukemia Immunotherapy Gets 90 Pct Remission

Robot for MRI-Guided Epilepsy Surgery in Development

By Alan, on October 16th, 2014%

Mockup of surgical robot designed to treat epilepsy (Vanderbilt University)

16 October 2014. Engineers at Vanderbilt University in Nashville are building a robot for epilepsy surgery guided by MRI scans and designed to be less invasive than current surgical methods. The team from Vanderbilt, with colleagues from Georgia Tech and Milwaukee School of . . . → Read More: Robot for MRI-Guided Epilepsy Surgery in Development

Needleless Delivery Start-Up Lands $11M First-Round Funding

By Alan, on October 15th, 2014%

Ian Hunter (Mass. Institute of Technology)

15 October 2014. Portal Instruments Inc., a new enterprise developing needless injections for biologic therapies and other medications, raised $11 million in its first round of venture funding. Financing for the Cambridge, Massachusetts company was led by the Sunrise division of drug maker Sanofi, venture capital company PBJ . . . → Read More: Needleless Delivery Start-Up Lands $11M First-Round Funding

Astellas, Harvard Partner on Retinitis Pigmentosa Targets

By Alan, on October 14th, 2014%

Constance Cepko (Harvard Medical School)

14 October 2014. Astellas Pharma Inc. in Tokyo is collaborating with a genetics and ophthalmology lab at Harvard University to discover more about the onset of the eye disease retinitis pigmentosa and identify therapy targets. Financial details of the three-year deal with Harvard were not disclosed.

Retinitis pigmentosa . . . → Read More: Astellas, Harvard Partner on Retinitis Pigmentosa Targets

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise